| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |